Liquidia (NASDAQ:LQDA) CEO Roger Jeffs Sells 66,610 Shares

13 Jan 2026, 17:18 by Jessica Moore · The Cerbat Gem

Liquidia Corporation (NASDAQ:LQDA – Get Free Report) CEO Roger Jeffs sold 66,610 shares of Liquidia stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $37.43, for a total transaction of $2,493,212.30. Following the completion of the transaction, the chief executive officer directly owned 1,037,528 shares of the company’s stock, valued at $38,834,673.04. This trade represents a 6.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Liquidia Stock Up 4.1%

Shares of NASDAQ:LQDA traded up $1.49 during trading on Tuesday, reaching $38.09. 2,055,159 shares of the stock traded hands, compared to its average volume of 2,814,845. The stock has a market cap of $3.31 billion, a P/E ratio of -26.45, a price-to-earnings-growth ratio of 1.19 and a beta of 0.48. The company has a debt-to-equity ratio of 6.19, a quick ratio of 1.96 and a current ratio of 2.20. The stock has a 50-day moving average of $31.94 and a two-hundred day moving average of $25.40. Liquidia Corporation has a 52-week low of $11.26 and a 52-week high of $39.29.

Liquidia (NASDAQ:LQDA – Get Free Report) last announced its quarterly earnings data on Monday, November 3rd. The company reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.45) by $0.41. Liquidia had a negative net margin of 176.04% and a negative return on equity of 296.78%. The company had revenue of $54.34 million during the quarter, compared to analyst estimates of $18.86 million. Liquidia’s revenue was up 1106.7% on a year-over-year basis. As a group, sell-side analysts expect that Liquidia Corporation will post -1.51 earnings per share for the current fiscal year.

More Liquidia News

Here are the key news stories impacting Liquidia this week:

Positive Sentiment: Short interest fell materially in December — short interest declined 18.1% to 10,709,682 shares as of Dec. 31 (about 17.6% of shares were sold short) and the days-to-cover was ~11.6. Fewer active shorts can reduce downside pressure and may have contributed to the stock moving higher. (Market data entry)
Neutral Sentiment: January short-interest data shows 0 shares as of Jan. 12 — this is almost certainly a reporting or data glitch rather than a real liquidation of all short positions. Investors should monitor the next short-interest report for a corrected figure. (Market data entry)
Negative Sentiment: CEO Roger Jeffs sold 66,610 shares at an average $37.43 (≈$2.49M); his stake decreased ~6.03%. This large insider sale may be seen as a negative signal by some investors. SEC Filing
Negative Sentiment: CFO Michael Kaseta sold 36,932 shares at $37.43 (≈$1.38M); his holding fell ~9.52%. SEC Filing
Negative Sentiment: General Counsel Russell Schundler sold 27,289 shares at $37.43 (≈$1.02M); his holding fell ~4.50%. SEC Filing
Negative Sentiment: Other insiders (including Rajeev Saggar, Jason Adair, Scott Moomaw, Sarah Krepp, CAO Dana Boyle) also executed sales on Jan. 12 at ~$37.43 per share, each reducing positions between ~6–11.7%. These combined sales represent significant insider liquidity taken at current prices. Rajeev Saggar SEC Filing Dana Boyle SEC Filing Jason Adair SEC Filing Scott Moomaw SEC Filing Sarah Krepp SEC Filing

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on LQDA shares. Wells Fargo & Company assumed coverage on Liquidia in a report on Monday, October 20th. They issued an “overweight” rating and a $31.00 price objective for the company. Wall Street Zen raised shares of Liquidia from a “hold” rating to a “buy” rating in a report on Saturday. BTIG Research reissued a “buy” rating and set a $49.00 price objective on shares of Liquidia in a report on Friday. Needham & Company LLC increased their price objective on shares of Liquidia from $36.00 to $52.00 and gave the company a “buy” rating in a research report on Tuesday, November 4th. Finally, Raymond James Financial restated a “strong-buy” rating and issued a $47.00 target price on shares of Liquidia in a report on Tuesday, November 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Liquidia presently has an average rating of “Moderate Buy” and an average target price of $39.67.

Read Our Latest Analysis on Liquidia

Institutional Trading of Liquidia

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. XTX Topco Ltd bought a new stake in shares of Liquidia in the second quarter worth about $1,485,000. Tyro Capital Management LLC purchased a new position in Liquidia during the 2nd quarter valued at approximately $15,473,000. Diametric Capital LP increased its stake in Liquidia by 72.5% in the 2nd quarter. Diametric Capital LP now owns 148,601 shares of the company’s stock worth $1,852,000 after acquiring an additional 62,443 shares during the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in shares of Liquidia during the 2nd quarter worth approximately $775,000. Finally, Pale Fire Capital SE purchased a new stake in shares of Liquidia during the 2nd quarter worth approximately $1,068,000. 64.54% of the stock is owned by hedge funds and other institutional investors.

Liquidia Company Profile

(Get Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.